SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 23rd, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledJanuary 23rd, 2015 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of January 21, 2015, is entered into by and between Innovus Pharmaceuticals, Inc., a Nevada corporation, (the “Company”), and LYNNETTE DILLEN (the “Buyer”).
ContractWarrant Agreement • January 23rd, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledJanuary 23rd, 2015 Company Industry JurisdictionTHIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THIS WARRANT AND THE COMMON STOCK ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS WARRANT UNDER SUCH ACT AND ANY APPLICABLE STATE SECURITIES LAW OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO INNOVUS PHARMACEUTICALS, INC. THAT SUCH REGISTRATION IS NOT REQUIRED.
EMPLOYMENT AGREEMENTEmployment Agreement • January 23rd, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations • California
Contract Type FiledJanuary 23rd, 2015 Company Industry JurisdictionThis Employment Agreement (the “Agreement”) is entered into by and between Lynnette Dillen (“you” or “your”) and Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”). This Agreement has an effective date of January 21, 2015 (the “Effective Date”).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • January 23rd, 2015 • Innovus Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 23rd, 2015 Company IndustryThis Amendment (this “Amendment”), is entered into as of January 21, 2015 and amends the Employment Agreement, dated as of January 22, 2013 (the “Employment Agreement”) by and between Innovus Pharmaceuticals, Inc., a Nevada corporation (the “Company”) and Bassam Damaj, a California citizen (“Dr. Damaj”).